BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Radiology (1981) 54, 500-504
© 1981 British Institute of Radiology
doi:
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spiers, F. W.
Right arrow Articles by Whitwell, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spiers, F. W.
Right arrow Articles by Whitwell, J. R.

The British Journal of Radiology, Vol 54, Issue 642 500-504, Copyright © 1981 by British Institute of Radiology

ARTICLES

Mean skeletal dose factors for beta-particle emitters in human bone. Part II: surface-seeking radionuclides

FW Spiers, AH Beddoe and JR Whitwell

Mean skeletal dose factors for surface-seeking beta-emitting radionuclides have been derived on the basis of the beta-particle dose factors calculated for human bones by Spiers et al. (1978b), or from empirical formulae representing these calculations given by Beddoe and Spiers (1979). The dose factors are derived for the same tissues as in Part I (Spiers et al., 1978a), namely, (1), sDM/Dskel, the mean dose to haemopoietic marrow in trabecular bone, and (2), sDs/Dskel, the mean dose to endosteal tissues lying in a zone 0-10 microns from trabecular surfaces. The dose factors are given as fractions of Dskel, the "dose to bone", calculated from the energy released by the retained radionuclide divided by the total mass of mineral bone. As in Part I, the dose factors are given for three ages, 1.7, 9 and 44 years and extrapolation to lower ages is made on the basis of calculations for a lumbar vertebra of an infant aged 3.5 weeks. The factors are given for six radionuclides covering a range of mean beta-particle energies from 0.0255 MeV (171Tm) to 0.93 MeV (90Y). The dosimetry is also considered for some radionuclides that first deposit on bone surfaces before being translocated to the bone volume. In the case of 45Ca, for example, it is shown that the dose calculation that includes both the surface and the volume depositions gives integrated doses to ten days and 100 days that are respectively 4.5 and 1.9 times the corresponding values calculated conventionally on a volume deposition only. Endosteal dose factors are similarly considered, and other radionuclides included as surface-plus-volume depositions are 47Ca, 89Sr and 90Sr + 90Y.


This article has been cited by other articles:


Home page
 JNMHome page
R. Syed, J. Bomanji, N. Nagabhushan, I. Kayani, A. Groves, W. Waddington, A. Cassoni, and P. J. Ell
186Re-HEDP in the Treatment of Patients with Inoperable Osteosarcoma
J. Nucl. Med., December 1, 2006; 47(12): 1927 - 1935.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 1981 by the British Institute of Radiology.